<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[BRDT promotes ovarian cancer cell growth.

Bromodomain testis-specific factor (BRDT) is a member of the bromodomain and 
extra-terminal (BET) family proteins. Its expression and potential functions in 
ovarian cancer were examined. We show that BRDT is overexpressed in human 
ovarian cancer tissues and in established (CaOV3)/primary ovarian cancer cells. 
However, its expression is low in ovarian epithelial tissues and cells. 
Significantly, shRNA-induced silencing or CRISPR/Cas9-mediated knockout of BRDT 
inhibited ovarian cancer cell growth, viability, proliferation and migration, 
and induced significant apoptosis activation. Conversely, exogenous 
overexpression of BRDT, by a lentiviral construct, augmented CaOV3 cell 
proliferation and migration. In CaOV3 cells expression of two key BRDT target 
genes, polo-like kinase 1 (PLK1) and aurora kinase C (AURKC), was downregulated 
by BRDT shRNA or knockout, but upregulated with BRDT overexpression. In vivo, 
xenograft tumors-derived from BRDT-knockout CaOV3 cells grew significantly 
slower than control tumors in severe combined immunodeficient (SCID) mice. 
Furthermore, intratumoral injection of BRDT shRNA lentivirus potently inhibited 
the growth of primary ovarian cancer xenografts in SCID mice. Downregulation of 
PLK1 and AURKC was detected in BRDT-knockout and BRDT-silenced tumor tissues. 
Collectively, BRDT overexpression promotes ovarian cancer cell progression. 
Targeting BRDT could be a novel strategy to treat ovarian cancer.]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="473~510" text="CRISPR/Cas9-mediated knockout of BRDT" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P1" spans="649~709" text="exogenous  overexpression of BRDT, by a lentiviral construct" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P3" spans="941~960" text="BRDT overexpression" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P4" spans="896~906" text="BRDT shRNA" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P5" spans="1002~1015" text="BRDT-knockout" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P6" spans="1163~1184" text="BRDT shRNA lentivirus" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P7" spans="1317~1330" text="BRDT-knockout" perturbingaction="gene loss-of-function" />
<PERTURBING_ACTION id="P8" spans="1335~1348" text="BRDT-silenced" perturbingaction="rnai/knockdown" />
<PERTURBING_ACTION id="P9" spans="1379~1398" text="BRDT overexpression" perturbingaction="gene gain-of-function" />
<CONTEXT id="C0" spans="522~536" text="ovarian cancer" context="neoplasm" />
<CONTEXT id="C1" spans="721~731" text="CaOV3 cell" context="transformed cells" />
<CONTEXT id="C2" spans="962~969" text="In vivo" context="in vivo" />
<CONTEXT id="C3" spans="972~988" text="xenograft tumors" context="xenograft" />
<CONTEXT id="C4" spans="1016~1027" text="CaOV3 cells" context="transformed cells" />
<CONTEXT id="C5" spans="1078~1121" text="severe combined immunodeficient (SCID) mice" context="organism" />
<CONTEXT id="C6" spans="1068~1074" text="tumors" context="neoplasm" />
<CONTEXT id="C7" spans="1219~1252" text="primary ovarian cancer xenografts" context="xenograft" />
<CONTEXT id="C8" spans="1256~1265" text="SCID mice" context="organism" />
<CONTEXT id="C9" spans="1349~1362" text="tumor tissues" context="neoplasm" />
<CONTEXT id="C10" spans="1408~1427" text="ovarian cancer cell" context="transformed cells" />
<PHENOTYPE id="PH0" spans="537~548" text="cell growth" phenotype="cell growth" />
<PHENOTYPE id="PH1" spans="561~574" text="proliferation" phenotype="proliferation" />
<PHENOTYPE id="PH2" spans="579~588" text="migration" phenotype="migration" />
<PHENOTYPE id="PH3" spans="615~624" text="apoptosis" phenotype="apoptosis" />
<PHENOTYPE id="PH4" spans="733~746" text="proliferation" phenotype="proliferation" />
<PHENOTYPE id="PH5" spans="751~760" text="migration" phenotype="migration" />
<EFFECT id="E0" spans="512~521" text="inhibited" effect="negative" />
<EFFECT id="E1" spans="595~602" text="induced" effect="positive" />
<EFFECT id="E2" spans="625~635" text="activation" effect="positive" />
<EFFECT id="E3" spans="711~720" text="augmented" effect="positive" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P0" perturbing_actionText="CRISPR/Cas9-mediated knockout of BRDT" contextID="C0" contextText="ovarian cancer" phenotypeID="PH0" phenotypeText="cell growth" effectID="E0" effectText="inhibited" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P0" perturbing_actionText="CRISPR/Cas9-mediated knockout of BRDT" contextID="C0" contextText="ovarian cancer" effectID="E0" effectText="inhibited" phenotypeID="PH1" phenotypeText="proliferation" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P0" perturbing_actionText="CRISPR/Cas9-mediated knockout of BRDT" contextID="C0" contextText="ovarian cancer" phenotypeID="PH2" phenotypeText="migration" effectID="E0" effectText="inhibited" />
<ENTITY_LINKING id="EN3" perturbing_actionID="P0" perturbing_actionText="CRISPR/Cas9-mediated knockout of BRDT" contextID="C0" contextText="ovarian cancer" effectID="E1" effectText="induced" phenotypeID="PH3" phenotypeText="apoptosis" />
<ENTITY_LINKING id="EN4" perturbing_actionID="P0" perturbing_actionText="CRISPR/Cas9-mediated knockout of BRDT" contextID="C0" contextText="ovarian cancer" phenotypeID="PH3" phenotypeText="apoptosis" effectID="E2" effectText="activation" />
<ENTITY_LINKING id="EN5" perturbing_actionID="P1" perturbing_actionText="exogenous  overexpression of BRDT, by a lentiviral construct" contextID="C1" contextText="CaOV3 cell" effectID="E3" effectText="augmented" phenotypeID="PH4" phenotypeText="proliferation" />
<ENTITY_LINKING id="EN6" perturbing_actionID="P1" perturbing_actionText="exogenous  overexpression of BRDT, by a lentiviral construct" contextID="C1" contextText="CaOV3 cell" phenotypeID="PH5" phenotypeText="migration" effectID="E3" effectText="augmented" />
</TAGS>
</Genomics_ConceptTask>